
51 - 200 employees
Founded 2015
🏥 Healthcare
🧬 Biotechnology
⚕️ Healthcare Insurance
Healthcare • Biotechnology • Healthcare Insurance
ProKidney Corp. is a late clinical-stage biotechnology company focused on pioneering cell therapy as a treatment for Chronic Kidney Disease (CKD). Their innovative approach aims to transform the therapeutic options available for advanced CKD by preserving kidney function, potentially delaying or eliminating the need for dialysis. With a focus on an area of high unmet medical need, ProKidney's cell therapy candidate, rilparencel, is at the forefront of clinical studies to provide alternative solutions for patients with limited treatment options. The company is committed to advancing its pipeline through clinical and regulatory developments and actively participates in healthcare conferences to bring attention to its groundbreaking work in CKD treatment.
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🕒 August 20
Statistical Programmer Contractor developing SAS datasets, tables, listings, and figures for ProKidney’s clinical studies. Supporting CDISC-compliant analysis and regulatory submissions.
🕒 August 20
Statistical Programmer Contractor developing SAS datasets, tables, listings, and figures for ProKidney’s clinical studies. Supporting SDTM/ADaM submissions, validation, documentation, and regulatory compliance.
🕒 August 19
Senior Director leading biostatistics for ProKidney's pivotal Phase 3 kidney cell therapy program. Driving clinical-trial analysis, FDA interactions, and BLA submission readiness.